Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.83 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.70 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | APP | P05067 | 5/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14992789 | 1.00 | ATM (0.83) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL12975138 | 1.00 | ATM (0.83) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL2945977 | 1.00 | ATM (0.83) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL2944637 | 0.93 | ATM (0.72) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL2944638 | 0.93 | ATM (0.72) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL21247451 | 0.92 | HCAR2 (0.79) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL5049800 | 0.92 | HCAR2 (0.79) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL21247449 | 0.92 | HCAR2 (0.79) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1656850 | 0.92 | ATM (0.70) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL1656848 | 0.92 | ATM (0.70) | ATMHCAR2TSHRHPGDMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105899484-A | Chemical process for conversion of mucic acid to adipic acid | 新加坡科技研究局 | 2016-08-24 | — | — | CN | claimed |
| EP-3749634-B1 | SYNTHESIS AND PURIFICATION OF MUCONIC ACID ESTER FROM ALDARIC ACID ESTERS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2026-05-20 | — | — | EP | disclosed |
| US-10968161-B2 | Synthesis and purification of muconic acid ester from aldaric acid esters | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210047260-A1 | Synthesis and purification of muconic acid ester from aldaric acid esters | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2021-02-18 | — | — | US | disclosed |
| EP-3749634-A1 | SYNTHESIS AND PURIFICATION OF MUCONIC ACID ESTER FROM ALDARIC ACID ESTERS | Teknologian Tutkimuskeskus VTT Oy (FI) | 2020-12-16 | — | — | EP | disclosed |
| EP-3154927-B1 | METHOD FOR PRODUCING MUCONIC ACIDS AND FURANS FROM ALDARIC ACIDS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2020-11-25 | — | — | EP | disclosed |
| WO-2019155128-A1 | SYNTHESIS AND PURIFICATION OF MUCONIC ACID ESTER FROM ALDARIC ACID ESTERS | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2019-08-15 | — | — | WO | disclosed |
| US-9969669-B2 | Method for producing muconic acids and furans from aldaric acids | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2018-05-15 | — | — | US | disclosed |
| US-9969669-B2 | Method for producing muconic acids and furans from aldaric acids | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2018-05-15 | — | — | US | disclosed |
| US-20170137363-A1 | Method for producing muconic acids and furans from aldaric acids | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY (FI) | 2017-05-18 | — | — | US | disclosed |
| US-8367859-B2 | Cyclohexane 1,4 carboxylates | Amyris, Inc. (US) | 2013-02-05 | — | — | US | disclosed |
| US-20110288310-A1 | CYCLOHEXANE 1,4 CARBOXYLATES | DRATHS CORPORATION (US) | 2011-11-24 | — | — | US | disclosed |
| US-20110288263-A1 | BIOBASED POLYESTERS | DRATHS CORPORATION (US) | 2011-11-24 | — | — | US | disclosed |
| US-20110288311-A1 | NOVEL TEREPHTHALIC AND TRIMELLITIC BASED ACIDS AND CARBOXYLATE DERIVATIVES THEREOF | DRATHS CORPORATION (US) | 2011-11-24 | — | — | US | disclosed |
| US-20110282078-A1 | CYCLOHEXENE 1,4 -CARBOXYLATES | DRATHS CORPORATION (US) | 2011-11-17 | — | — | US | disclosed |
| US-20100314243-A1 | PREPARATION OF TRANS,TRANS MUCONIC ACID AND TRANS,TRANS MUCONATES | DRATHS CORPORATION (US) | 2010-12-16 | — | — | US | disclosed |
| US-7727677-B2 | Nonaqueous electrolyte solution and lithium secondary battery using same | UBE INDUSTRIES, LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| EP-1758198-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | UBE INDUSTRIES (JP) | 2009-07-08 | — | — | EP | disclosed |
| US-20080038644-A1 | Nonaques Electrolyte Solution And Lithium Secondary Battery Using Same | UBE INDUSTRIES, LTD. (JP) | 2008-02-14 | — | — | US | disclosed |
| EP-1758198-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | Ube Industries, Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288310-A1 | CYCLOHEXANE 1,4 CARBOXYLATES | CNR2, CBR1, CCR4 | ATM 3706/4885HCAR2 102/4885TSHR 4873/4885 |
| US-20170137363-A1 | Method for producing muconic acids and furans from aldaric acids | ACSL6, FASN, CYP2A6 | ATM 1202/4885HCAR2 271/4885TSHR 2959/4885 |
| US-20110282078-A1 | CYCLOHEXENE 1,4 -CARBOXYLATES | CBR1, MCM4, CCR4 | ATM 3842/4885HCAR2 172/4885TSHR 4840/4885 |
| US-10968161-B2 | Synthesis and purification of muconic acid ester from aldaric acid esters | MUC1, ACACA, ADH1A | ATM 801/4885HCAR2 584/4885TSHR 4451/4885 |
| US-20110288311-A1 | NOVEL TEREPHTHALIC AND TRIMELLITIC BASED ACIDS AND CARBOXYLATE DERIVATIVES THEREOF | TRIM4, DDT, PICALM | ATM 4087/4885HCAR2 164/4885TSHR 4009/4885 |
| US-20100314243-A1 | PREPARATION OF TRANS,TRANS MUCONIC ACID AND TRANS,TRANS MUCONATES | MUC1, FUT6, ST6GAL1 | ATM 1314/4885HCAR2 1620/4885TSHR 762/4885 |
| US-20210047260-A1 | Synthesis and purification of muconic acid ester from aldaric acid esters | MUC1, ACACA, ADH1A | ATM 801/4885HCAR2 584/4885TSHR 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.